High Performance Dry Binding with HPC-SSL Super Fine Powder



Similar documents
High Performance Dry Binding with CELNY-SSL Super Fine Powder

Table 1. Pure superdisintegrant tablet formulation. Material % w/w Weight (mg) Superdisintegrant Stearic acid 1 2.

STARCH Application Data

PREPARATION AND EVALUATION OF STARCH PHOSPHATE- A NEW MODIFIED STARCH AS A DISINTEGRANT IN TABLET FORMULATIONS

The importance of normalisation when comparing tablet properties

MATERIAL SAFETY DATA SHEET

EUDRAGIT E 100, EUDRAGIT E PO and

It is an important tool to assess factors that affect the bioavailability of a drug from a solid preparartion.

Trade Name of this Product Isopropyl Rubbing Alcohol 91% USP. Corporate Compliance Team 1666 East Touhy Avenue

Material Safety Data Sheet

GENERAL GUIDANCE FOR INSPECTORS ON HOLD-TIME STUDIES

Single Base Powders SAFETY DATA SHEET March The following smokeless powders are distributed by IMR Legendary Powders

Material Safety Data Sheet

SAFETY DATA SHEET According to 91/155 EC

Material Safety Data Sheet

AMBERLITE IRP64 Pharmaceutical Grade Cation Exchange Resin (Polacrilex Resin)

MATERIAL SAFETY DATA SHEET High Pressure Laminate Fire Retardant

Material Safety Data Sheet

Material Safety Data Sheet. Accepta Statham House Talbot Road Manchester M32 0FP

MATERIAL SAFETY DATA SHEET

Directly compressed mini-tablets coated in a solid-wall pan for sustained drug release

Vinod et al., ARPB, 2013; Vol 3 (II) ISSN

EU Safety Data Sheet. Vival NF. Vival NF

SODIUM CARBOXYMETHYL CELLULOSE

Material Safety Data Sheet

Swallowed Do not induce vomiting give 250 ml water to drink. Seek immediate medical attention.

Material Safety Data Sheet

SAFETY DATA SHEET 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND COMPANY/UNDERTAKING PERSPEX CAST ACRYLIC SHEET: CLEARS AND TRANSPARENTS

Formulation and Evaluation of Didanosine Enteric Coated Sustained Release Tablet

Safety Data Sheet Aluminium profiles Apply for alloys Sapa EN AW 6060, 6063, 6005, 6005A, 6082, yellow chromated, with or without powder coating.

How To Test A Base Axe

REVISION NO : 3 August 2010

MATERIAL SAFETY DATA SHEET Page 1 of 5 DURAFIX Solder for Aluminum, Diecast, Zinc Alloys, Pot Metal and White Metal

MATERIAL SAFETY DATA SHEET

MATERIAL SAFETY DATA SHEET. PRODUCT IDENTIFIER Carbon Dioxide, Refrigerated Liquid

Material Safety Data Sheet

Safety Data Sheet Dry Vitamin D3 100 HP Revision date : 2012/09/18 Page: 1/7

Material Safety Data Sheet

Research Article Prospective Validation of Paracetamol Tablet Dosage Form

SAFETY DATA SHEET Revised edition no : 0 SDS/MSDS Date : 12 / 7 / 2012

Material Safety Data Sheet

Material Safety Data Sheet according to Regulation (EC) No. 1907/2006 (REACH) 1 Identification of the substance/mixture and of the company/undertaking

FORMULATION EVALUATION AND OPTIMIZATION OF AN ORAL IMMEDIATE RELEASE ANTIBIOTIC FORMULATION OF AMOXICILLINE

Solid dosage forms testing: Disintegration test and tablet friability and hardness

Material Safety Data Sheet

Date Printed: 03/31/2008 Date Updated: 02/01/2006 Version 1.4

Emergency Phone Numbers: P.O. Box 1950 CHEMTREC: 800/ Brewster, New York POISON CENTER: 800/ /

MATERIAL SAFETY DATA SHEET

**** MATERIAL SAFETY DATA SHEET **** STABIL Fuel Stabilizer **** SECTION 1 - CHEMICAL PRODUCT AND MANUFACTURER IDENTIFICATION ****

MATERIAL SAFETY DATA SHEET

FOR PLANT PROTECTION PRODUCTS FOOD AND AGRICULTURE ORGANIZATION OF THE UNITED NATIONS

Material Safety Data Sheet

SHINKOLITE, Mitsubishi Rayon Co., Ltd, June 22, 2015 Page 1/5 SAFETY DATA SHEET

MATERIAL SAFETY DATA SHEET

Material Safety Data Sheet

MATERIAL SAFETY DATA SHEET

PETER GREVEN Your partner for food/feed, pharma & cosmetic additives (FPC)

Performance Evaluation of Actimask 92S Ibuprofen: A Novel Taste-Masked Ibuprofen for Use in Orally-Dispersible Dosage Forms

Fila Chemicals USA FILA CR CHEMTREC

QbD Understanding How Excipient Properties Influence Solid Oral Dosage Form Performance

SAFETY DATA SHEET. according to 1907/2006/EC, Article 31 CYTOFIXX (CYTOLOGICAL FIXATIVE)

Date Printed: 08/29/2005 Date Updated: 03/07/2004 Version 1.4. CERIUM(III) NITRATE HEXAHYDRATE, 99.99% Product Number

Product Code: VLB ml cartridges. Substance Name EC No. CAS No. % by Wt Hazard Symbols n Butylacetate

CAS-No. EC-No. Index-No. Concentration Benzyl carbazate

Material Safety Data Sheet

CeramClean II Aluminum Safe

PARALOID KM-1 Acrylic Impact Modifier

Safety Data Sheet according to 1907/2006/EC, Article 31 Printing date: Revision:

Physical & Chemical Properties. Properties

Ingredient CAS Number Weight % ACGIH TLV PEL STEL Phosphoric Acid mg/m3 1 mg/m3 3 mg/m3

DOW CORNING CORPORATION Material Safety Data Sheet

THE PHARMACEUTICAL INDUSTRY

UltraClean Soil DNA Isolation Kit

Safety data sheet. according to 1907/2006/EC, Article Revision: Printing date:

Safety Data Sheet (SDS)

Product Bulletin INTEROX HYDROGEN PEROXIDE

5/13/2010. Excipient Fest Porto Rico May PDF created with pdffactory Pro trial version Location

MATERIAL SAFETY DATA SHEET

Material Safety Data Sheet

Material Safety Data Sheet

Product list Magnesium, Calcium and further mineral compounds

MATERIAL SAFETY DATA SHEET

WATER CHEMISTRY AND POOL WATER BALANCE

SAFETY. CAS# Chloro-1,2-Propanediol 98% Hazard Symbols: T Risk Phrases: 23/24/25

Magnesium Ascorbyl Phosphate msds

SOLVENT CLEANER MSDS Page 1 of 5 SAFETY DATA SHEET. (To comply with OSHA s Hazard Communication Standard 29CFR /ANSI z400.

FAO SPECIFICATIONS FAO PLANT PROTECTION PRODUCTS. THIRAM tetramethylthiuram disulphide

DuPont SUVA 123 Refrigerant

Saint Gobain Gyproc India Ltd. (Formerly India Gypsum Ltd.)

PRODUCT DEVELOPMENT GUIDE

CAS NO. A >94.19 % WT >94.19 % VOL SARA 313 NO

SAFETY DATA SHEET Revised edition no : 0 SDS/MSDS Date : 12 / 7 / 2012

SAFETY DATA SHEET (according to EC directive 93/112/EC) Update : Version: 2.0 Date : TEGOAMIN BDE 100

Double Base Powders - Enduron SAFETY DATA SHEET March The following smokeless powders are distributed by IMR Legendary Powders

MATERIAL SAFETY DATA SHEET Description: SAF DRAIN Revision Number: 00

MATERIAL SAFETY DATA SHEET WWF of 5 1 Gal Xtreme Blue -20 Windshield Washer Fluid. 121 Landmark Drive Greensboro, NC 27409

Safety Data Sheet Vitamin B12 1% SD Revision date : 2015/03/05 Page: 1/8

Transcription:

NOTE #: Application: DC-ODT-2 Direct Compression/ ODT Formulation High Performance Dry Binding with HPC-SSL Super Fine Powder Application note Introduction (Super Fine Powder), a highly compressible grade of HPC, is introduced for dry binding applications. With a very fine particle size and low molecular weight, imparts the expected HPC advantages in tablet hardness and friability at lower usage amounts and with faster dissolution when compared to regular HPC and other commonly used excipients. CONTENTS page Features and Applications 2 Powder Properties 2 Methods Used in this Application Note 2 Comparison to Other Dry Binders 3 Comparison of Direct Compression (DC) 4 and Wet Granulation Methods Extra-Granule Addition Application 5 Orally Disintegrating Tablet (ODT) Application 6 Specifications 7 Cautions, Reactivity, Packaging 8

1. Features of HPC-SSL Super Fine Powder is highly compressible, giving superior tablet properties at low usage levels in dry binding applications. is super low viscosity and super fine particle size, allowing fast disintegration and fast dissolution times that are not possible with regular HPC grades. provides HPC s well-known advantages in improved tablet hardness and friability. 2. Applications Direct compression Extra-granule dry addition Orally Disintegrating Tablet (ODT) Dry granulation/roller compaction High drug load binding Downsizing of tablet Anti-capping 3. Molecular Weight and Powder Properties Reference to other HPC grades (super fine powder) HPC-SL-FP (fine powder) HPC-L (regular powder) Molecular weight 4, 1, 14, D 5 /D 9 (µm) 2/5 8/16 17/37 Angle of repose (degree) 53 47 45 Bulk density (loose/packed).18/.33.32/.48.37/.55 Note on Methods used in this Application Note Direct compression: Powder for tablet was prepared by dry-mixing of materials except Magnesium Stearate in PE bag for three minutes. This was followed by addition of Magnesium Stearate and further dry-mixing for 3 seconds. Laboratory scale rotary tablet press machine was used to compress tablet at 1 kn of compression force. Tablet weight and diameter were 2 mg and 8 mm respectively. Wet granulation (Fluidized Bed): Acetaminophen, lactose and corn starch were pre-mixed in PE bag for three minutes and added to the granulator, followed by granulation with spraying 8% aqueous solution of HPC-SSL at spray speed of 5 ml/min and drying. Powder for tablet was prepared by dry-mixing granules of 3 mesh pass and Magnesium Stearate for 3 seconds. Laboratory scale rotary tablet press machine was used to compress tablet at 1 kn of compression force. Tablet weight and diameter were 2 mg and 8 mm respectively. Tablet properties test methods: Tablet hardness was measured as average of 1 tablets per lot. Friability and disintegration time was measured according to JP method. Release rate of acetaminophen was also measured according to JP method and concentration of acetaminophen at each time point was determined by measurement of absorbance at 243 nm with UV spectrophotometer. Nisso HPC 2

4. Comparison to Other Commonly Used Dry Binders is compared to several other commonly used dry binders in a direct compression acetaminophen. a) Formulation Other binders Acetaminophen (%) 6 6 Lactose (%) 22.8 24.2 25.6 17.2 Corn starch (%) 9.7 1.3 1.9 7.4 (%) 7 5 3 - Other binders (%) - 15 Magnesium Stearate (%).5.5 Silica (%).5.5 Compression pressure 1 kn, Tablet weight 2 mg Other binders: HPC-SL (FP), MCC PH-11, PVP-PVA (PLASDONE S63), L-HPC (LH-21), Partially Pregelatinized Maize Starch (Starch 15) b) Results Tablet hardness (kgf) Disintegration time (min) Friability (%) 7% 5% 3% HPC-SL-FP 15% MCC-PH-11 15% PVP-PVA 15% 16.22 L-HPC 15% Partially Pregelatinized Maize Starch 15% 2 4 6 8 1 12 2 4 6 8 1..2.4.6.8 1. 1.2 12 Dissolution Profile 3% Drug Released (%) 1 8 6 4 2 1 2 3 4 5 6 7 5% 7% HPC-SL-FP 15% MCC-PH-11 15% PVP-PVA 15% L-HPC 15% Partially Pregelatinized Maize Starch 15% c) Conclusion is an excellent dry binder that can provide harder tablet hardness and less friability with much lower use level than other dry binders, while also having fast disintegration time and drug release. Nisso HPC 3

5. Comparison of Direct Compression and Wet Granulation Methods is used as a dry binder in a Direct Compression acetaminophen formulation and is compared to the same formulation using HPC-SSL (regular type) as a wet binder in a fluidized bed granulation application. Tablet properties and drug release by both methods are evaluated. a) Formulation Wet Granulation Method Direct Compression Method Acetaminophen % 3 3 Lactose % 49 49 Corn Starch % 21 21 % - 3 HPC-SSL % 3 - Silica %.5.5 Magnesium Stearate %.5.5 b) Results Wet Granulation HPC-SSL Tablet Properties Direct Compression HPC- SSL-SFP 12 1 Dissolution Profile Hardness (kgf) 1.63 9.57 Friability (%).18.24 Disintegration 2.28 1.33 Drug Released (%) 8 6 4 2 HPC-SSL 3% 3% 12 1 2 3 4 5 1 Drug Released (%) c) Conclusion 8 6 Direct Compression Method with was found to provide equivalent properties to, and faster drug release 4 3% than tablet prepared by fluidized bed method with HPC-SSL. It is suggested that formulations prepared by wet 2 granulation method could also be done by DC method using without deterioration of tablet properties or hindering drug release in the case of low drug load formulation. 1 2 3 4 5 HPC-SSL 3% Nisso HPC 4

6. Extra-Granule Addition Application is compared to a one of Nisso s other HPC grades to show the impact of moving to the super low viscosity and super fine particle size when HPC is added as an extra-granule dry powder. a) Formulation and process Granulation: Erythritol 8% + Corn Starch 2% Extra-granule HPC addition: -5% Erythritrol 8% Corn Starch 2% Fluidized Bed Granulation HPC Mixing %,3%,5% HPC-SL-FP %, 3% Mixing Magnesium Stearate.5% Tabletting Compression force: 1kN Tablet size: 2mg, 8 mm Ø b) Results Tablet hardness (kgf) Friability (%) Disintegration 11. SSL-SFP 1. SL-FP 9. 8. 7. 6. 5. 4. 3. 2. 1... 1. 2. 3. 4. 5. HPC addition (%) 3.5 SSL-SFP SL-FP 3. 2.5 2. 1.5 1..5.. 1. 2. 3. 4. 5. HPC addition (%) 3. SSL-SFP Friability (%) SL-FP 2.5 2. 1.5 1..5.. 1. 2. 3. 4. 5. HPC addition (%) c) Conclusion The excellent compression formability of is effective for improvement of tablet properties at low use level by extra-granule addition method. Nisso HPC 5

7. Orally Disintegrating Tablet (ODT) application A small amount of is added to a conventional MCC-based ODT. Tablet properties and stability are evaluated for both formulations. a) Formulation Acetaminophen % 6 6 MCC PH-12 % 37.5 34.5 Compression pressure 1 kn, Tablet weight 2 mg % - 3 Crospovidone % 2 2 Silica %.5.5 Magnesium Stearate %.5.5 b) Results Tablet properties Hardness (kgf) 5.16 7.13 Friability (%).57.29 Disintegration time (sec) 1 22 Hardness (kgf) 1 8 6 4 2 Hardness Stability Friability Stability Disintegration Time Stability Friability (%) 1.6 1.2.8.4 4 3 2 1 One day Four weeks One day Four weeks One day Four weeks c) Conclusion The addition of a small amount of to an ODT greatly improves the tablet properties and stability of those properties. Nisso HPC 6

8. Specifications <USP/NF> Test Items Unit Specifications Grade Viscosity (2% aqueous solution at 2 C) mpa*s 2. 2.9 Identification ph 5. 8. Loss on drying % Not more than 5. Residue on ignition % Not more than.2 Lead ppm Not more than 1 Heavy metals ppm Not more than 2 Assay for Hydroxypropoxy groups % Not more than 8.5 Particle size (45 µm pass) % Not less than 99% <Ph. Eur.> Test Items Unit Specifications Grade Apparent viscosity (2% aqueous solution at 2 C) Identification (A F) Appearance of solution mpa*s 2. 2.9 ph 5. 8.5 Silica % Not more than.6 Chlorides % Not more than.5 Heavy metals ppm Not more than 2 Loss on drying % Not more than 7. Sulphated ash % Not more than 1.6 Particle size (45 µm pass) % Not less than 99% <JP> Test Items Unit Specifications Grade Viscosity (2% aqueous solution at 2 C) mpa*s 2. 2.9 Description Identification (1) (3) Clarity of solution White to yellowish white powder ph 5. 7.5 Chloride % Not more than.142 Sulfate % Not more than.48 Heavy metals ppm Not more than 2 Arsenic ppm Not more than 2 Loss on drying % Not more than 5. Residue on ignition % Not more than.5 Assay (Hydroxypropxy group) % 53.4 77.5 Particle size (45 µm pass) % Not less than 99% Nisso HPC 7

9. Cautions for handling Avoid raising excessive dust from powder. Ensure adequate ventilation. May form explosive dust-air mixtures. Keep away from heat, static and flame. Electrically ground and bond all equipment. Avoid contact with skin and eyes. Use gloves and safety glasses. Wash face and hands thoroughly after use. Refer to MSDS for complete safety handling instructions. 1. Stability and reactability Stable in normal conditions. Avoid strong oxidizing agents. Not flammable but combustible Dust explosion lower limit: 6 g/m 3 11. Packaging 1 kg box, double-lined PE bag 5 g box, double-lined PE bag www.nissoexcipients.com Head Office Nippon Soda Co., Ltd 2-1 2-Chome, Ohtemachi Chiyoda-ku, Tokyo 1-8165 Japan (T) 81-3-3245-6159 (F) 81-3-3245-659 info@nippon-soda.co.jp U.S./Canada Nisso America Inc. Wall Street Plaza 88 Pine Street, 14th Floor New York, NY 15 (T) 212-49-35 info@nissoamerica.com Europe Nisso Chemical Europe, GmbH Berliner Allee 42, 4212 Duesseldorf, Germany (T) +49-()-211-136686- (F) +49-()-211-328231 www.nisso-chem.de Copyright 212 Nisso HPC DC-ODT-2 Version 2.